Table 1 Baseline characteristics of participants included in the analyses
Characteristic | Children, n (%)a | Adults, n (%)a |
|---|---|---|
Study site | ||
 Walukuba | 318 (31.5%) | 113 (36.2%) |
 Kihihi | 357 (35.4%) | 95 (30.5%) |
 Nagongera | 335 (33.2%) | 104 (33.3%) |
Gender | ||
 Male | 516 (51.1%) | 19 (6.1%) |
 Female | 494 (48.9%) | 293 (93.9%) |
Haemoglobin variant | ||
 AA | 808 (80.7%) | 242 (78.3%) |
 AS | 188 (18.8%) | 67 (21.7%) |
 SS | 5 (0.5%) | 0 (0%) |
 No result | 9 | 3 |
Alpha thalassaemia variant | ||
 Normal | 585 (60.3%) | 200 (66.0%) |
 α−/αα | 335 (34.5%) | 84 (27.7%) |
 α−/−α | 50 (5.2%) | 19 (6.3%) |
 No result | 40 | 9 |
G6PD genotype (male) | ||
 Normal | 455 (89.4%) | 15 (79.0) |
 Hemizygotes | 54 (10.6%) | 4 (21.1%) |
 No result | 7 | 0 |
G6PD genotype (female) | ||
 Normal | 370 (75.5%) | 232 (79.5%) |
 Heterozygotes | 108 (22.0%) | 55 (18.8%) |
 Homozygotes | 12 (2.4%) | 5 (1.7%) |
 No result | 4 | 1 |